Syn Tech Chem Pharm Stock Book Value Per Share
| 1777 Stock | TWD 97.20 0.20 0.21% |
SYN Tech Chem Pharm fundamentals help investors to digest information that contributes to SYN Tech's financial success or failures. It also enables traders to predict the movement of SYN Stock. The fundamental analysis module provides a way to measure SYN Tech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to SYN Tech stock.
SYN |
SYN Tech Chem Pharm Company Book Value Per Share Analysis
SYN Tech's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current SYN Tech Book Value Per Share | 48.66 X |
Most of SYN Tech's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, SYN Tech Chem Pharm is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
In accordance with the recently published financial statements, the book value per share of SYN Tech Chem Pharm is about 48.664 times. This is 2962.59% lower than that of the Healthcare sector and 119.57% lower than that of the Biotechnology industry. The book value per share for all Taiwan stocks is 97.48% higher than that of the company.
SYN Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SYN Tech's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SYN Tech could also be used in its relative valuation, which is a method of valuing SYN Tech by comparing valuation metrics of similar companies.SYN Tech is currently under evaluation in book value per share category among its peers.
SYN Fundamentals
| Return On Equity | 0.14 | |||
| Return On Asset | 0.0391 | |||
| Profit Margin | 0.33 % | |||
| Operating Margin | 0.21 % | |||
| Current Valuation | 3.16 B | |||
| Shares Outstanding | 44.59 M | |||
| Shares Owned By Insiders | 59.32 % | |||
| Price To Earning | 16.06 X | |||
| Price To Book | 1.75 X | |||
| Price To Sales | 5.14 X | |||
| Revenue | 746.6 M | |||
| Gross Profit | 242.35 M | |||
| EBITDA | 192.76 M | |||
| Net Income | 103.83 M | |||
| Cash And Equivalents | 668.13 M | |||
| Cash Per Share | 22.25 X | |||
| Total Debt | 549.52 M | |||
| Debt To Equity | 51.20 % | |||
| Current Ratio | 1.55 X | |||
| Book Value Per Share | 48.66 X | |||
| Cash Flow From Operations | 120.43 M | |||
| Earnings Per Share | 5.68 X | |||
| Number Of Employees | 178 | |||
| Beta | 0.17 | |||
| Market Capitalization | 3.83 B | |||
| Total Asset | 2.71 B | |||
| Z Score | 3.6 | |||
| Annual Yield | 0.02 % | |||
| Five Year Return | 3.36 % | |||
| Net Asset | 2.71 B | |||
| Last Dividend Paid | 1.93 |
About SYN Tech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SYN Tech Chem Pharm's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SYN Tech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SYN Tech Chem Pharm based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with SYN Tech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SYN Tech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SYN Tech will appreciate offsetting losses from the drop in the long position's value.Moving against SYN Stock
| 0.52 | 2888 | Shin Kong Financial Earnings Call This Week | PairCorr |
| 0.47 | 6547 | Medigen Vaccine Biologics | PairCorr |
| 0.46 | 4743 | Oneness Biotech | PairCorr |
| 0.4 | 4174 | OBI Pharma | PairCorr |
| 0.35 | 4142 | Adimmune Corp | PairCorr |
The ability to find closely correlated positions to SYN Tech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SYN Tech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SYN Tech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SYN Tech Chem Pharm to buy it.
The correlation of SYN Tech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SYN Tech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SYN Tech Chem moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SYN Tech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for SYN Stock Analysis
When running SYN Tech's price analysis, check to measure SYN Tech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SYN Tech is operating at the current time. Most of SYN Tech's value examination focuses on studying past and present price action to predict the probability of SYN Tech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SYN Tech's price. Additionally, you may evaluate how the addition of SYN Tech to your portfolios can decrease your overall portfolio volatility.